Credits Available: 4.50 AMA PRA Category 1 Credit™, 4.5 ANCC Contact Hours, 4.5 ACPE credit

Description: This curriculum aims to evaluate the landscape of BC management, delving into the latest breakthroughs, therapies, and strategies that have transformed our approach to this complex and chronic condition. This curriculum is designed to offer you a thorough understanding of the wide range of treatment modalities available. From conventional methods to cutting-edge innovations, our goal is to equip you with the insights needed to make informed decisions for optimizing BC management, including use of ADCs, immunotherapy, PARP-inhibitors and a potential therapeutic algorithm for HER 2-low breast cancer.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Assistant, MBBS, Pharmacist
Target Specialties: Gynecologic Oncology, Oncology

David Page

Providence Cancer Institute
Medical Oncology

I am a medical oncologist and clinical investigator in the field of breast cancer and immunology. I attended medical residency at the New York Presbyterian / Columbia University Medical Center, followed by fellowship at Memorial Sloan Kettering Cancer Center. Currently I practice at the Providence Cancer Institute in Portland, OR. In addition to seeing patients, I also conduct clinical trials evaluating novel immunotherapy combinations in breast cancer, and I investigate novel biomarkers strategies (such astumor infiltrating lymphocyte spatial analysis) to help guide clinical decision-making in the context of immunotherapy.